Migergot Suppository
NDC Package 0713-0166-12

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Migergot (ergotamine tartrate and caffeine) suppositories is this combination medication is used to treat or prevent a certain type of headache (vascular headaches such as migraine headaches and cluster headaches). This formulation utilizes a suppository delivery system. Marketed by Cosette Pharmaceuticals, Inc., this product is identified by NDC 0713-0166 and is authorized under FDA application ANDA086557.

Identification & Billing

NDC Package Code
0713-0166-12
Package Description
12 SUPPOSITORY in 1 BOX
Product Code
0713-0166
11-Digit Billing Format
00713016612
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
12 EA
RxNorm Crosswalk
  • RxCUI: 1293508 - ergotamine tartrate 2 MG / caffeine 100 MG Rectal Suppository
  • RxCUI: 1293508 - caffeine 100 MG / ergotamine tartrate 2 MG Rectal Suppository
  • RxCUI: 1293639 - MIGERGOT 2 MG / 100 MG Rectal Suppository
  • RxCUI: 1293639 - caffeine 100 MG / ergotamine tartrate 2 MG Rectal Suppository [Migergot]
  • RxCUI: 1293639 - Migergot (caffeine 100 MG / ergotamine tartrate 2 MG) Rectal Suppository

Clinical Specifications

Proprietary Name
Migergot
Non-Proprietary Name
Ergotamine Tartrate And Caffeine
Substance Name
Caffeine; Ergotamine Tartrate
Dosage Form
Suppository - A solid body of various weights and shapes, adapted for introduction into the rectal orifice of the human body; they usually melt, soften, or dissolve at body temperature.
Administration Route
Rectal - Administration to the rectum.
Active Ingredient(s)
Pharmacologic Class
Usage Information
This combination medication is used to treat or prevent a certain type of headache (vascular headaches such as migraine headaches and cluster headaches). Ergotamine helps narrow widened blood vessels in the head, which reduces the throbbing effects of vascular headaches. Caffeine increases the effects of ergotamine by also narrowing the widened blood vessels in the head. The suppository form is used when medications cannot be taken by mouth (for example, due to nausea and vomiting).

Regulatory & Marketing

Labeler Name
Cosette Pharmaceuticals, Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA086557
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
10-30-1983
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0713-0166-12 identifies a specific commercial package of 12 suppository in 1 box of Migergot, a human prescription drug labeled by Cosette Pharmaceuticals, Inc.. This suppository is formulated for rectal use and contains caffeine; ergotamine tartrate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cosette Pharmaceuticals, Inc. on October 30, 1983. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This combination medication is used to treat or prevent a certain type of headache (vascular headaches such as migraine headaches and cluster headaches). Ergotamine helps narrow widened blood vessels in the head, which reduces the throbbing effects of vascular headaches. Caffeine increases the effects of ergotamine by also narrowing the widened blood vessels in the head. The suppository form is used when medications cannot be taken by mouth (for example, due to nausea and vomiting).

How is this Cosette Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00713016612. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 12 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0713-0166-12
11-Digit CMS (5-4-2)
00713-0166-12

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.